PMH15 COST-EFFECTIVENESS OF AMISULPRID COMPARED TO RISPERIDONE AND OLANZAPINE IN THE TREATMENT OF SCHIZOPHRENIA IN POLAND
Abstract
Authors
E Kowalik M Jakubczyk J Lis M Niewada
E Kowalik M Jakubczyk J Lis M Niewada
ISPOR recommends that you update your browser for more security, speed and the best experience on ispor.org. Update my browser now